Pleiotropic effects of HIV-1 protein R (Vpr) on morphogenesis and cell survival in fission yeast and antagonism by pentoxifylline

Virology

Volumn 246, Issue 2, 1998, Pages 266-276

  Zhao, Yuqi ^a   Yu, Min ^a   Chen, Mingzhong ^a   Elder, Robert T ^a   Yamamoto, Ayumu ^b   Cao, Jian ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL STRUCTURE; CELL SURVIVAL; CYTOSKELETON; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS REPLICATION; YEAST;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; RNA VIRUSES; SCHIZOSACCHAROMYCES POMBE;

EID: 0032486606     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9208     Document Type: Article

References (59)

1. Alfa, C. Fantes, P. Hyams, J. McLeod, M. Warbrick, E. 1993, Nutritional control of entry into stationary phase determined by flow fluorocytometry, In, Experiments with Fission Yeast: A Laboratory Course Manual, 52, 56, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
2. Basi G., Schmid E., Maundrell K. TATA box mutations in theSchizosaccharomyces pombnmt. Gene. 123:1993;131-136.
3. Biswas D. K., Ahlers C. M., Dezube B. J., Pardee A. B. Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression. Mol. Med. 1:1994;31-43.
4. Bouhamdan M., Benichou S., Rey F., Navarro J. M., Agostini I., Spire B., Camonis J., Slupphaug G., Vigne R., Benarous R., Sire J. Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70:1996;697-704.
5. Broker M. Transformation of intactSchizosaccharomyces pombe. BioTechniques. 5:1987;516.
6. Bromidge T. J., Howe D. J., Johnson S. A., Phillips M. J. Adaptation of the TdT assay for semi-quantitative flow cytometric detection of DNA strand breaks. Cytometry. 20:1995;257-260.
7. Chen I. S. Y., Withers-Ward E., Jowett J. B. M., Stewart S. A., Chow S., Sawutz D. New opportunities for HIV therapy from discovery to clinical proof-of-concept. Second Joint Conference of the Strategic Program for Innovative Research on AIDS Treatment (SPIRAT) and the National Cooperative Drug Discovery Groups for the Treatment of HIV Infection (NCDDG-HIV). 1997.
8. Chikashige Y., Ding D. Q., Funabiki H., Haraguchi T., Mashiko S., Yanagida M., Hiraoka Y. Telomere-led premeiotic chromosome movement in fission yeast. Science. 264:1994;270-273.
9. Cleves A. E., Novick P. J., Bankaitis V. A. Mutations in the Sac1 gene suppress defects in yeast Golgi and yeast actin function. J. Cell Biol. 109:1989;2939-2950.
10. Cohen G. M., Sun X. M., Snowden R. T., Dinsdale D., Skilleter D. N. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. 286:1992;331-334.
11. Dezube B. J., Pardee A. B., Chapman B., Beckett L. A., Korvick J. A., Novick W. J., Chiurco J., Kasdan P., Ahlers C. M., Ecto L. T. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. J. AIDS. 6:1993;787-794.
12. Fantes P. Control of cell size and cycle time inSchizosaccharomyces pombe. J. Cell Sci. 24:1977;51-67.
13. Forsburg S. L. Comparison ofSchizosaccharomyces pombe. Nucleic Acids Res. 21:1993;2955-2956.
14. Fraser A., Evan G. A license to kill. Cell. 85:1996;781-784.
15. Fringert H. J., Chang J. D., Pardee A. B. Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents. Cancer Res. 46:1986;2463-2467.
16. Gibbs J. S., Lackner A. A., Lang S. M., Simon M. A., Sehgal P. K., Daniel M. D., Desrosiers R. C. Progression to AIDS in the absence of a gene forvprvpx. J. Virol. 69:1995;2378-2383.
17. Gu J., Emerman M., Sandmeyer S. Small heat shock protein suppression of Vpr-induced cytoskeletal defects in budding yeast. Mol. Cell. Biol. 17:1997;4033-4042.
18. He J., Choe S., Walker R., Di Marzio P. D., Morgan D. O., Landau N. R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:1995;6705-6711.
19. Heinzinger N., Bukinsky M., Haggerty S., Ragland A., Kewalramani V., Lee M., Gendelman H., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA. 91:1994;7311-7315.
20. Hoch J., Lang S. M., Weeger M., Stahl-Hennig C., Coulibaly C., Dittmer U., Hunsmann G., Fuchs D., Müller J., Sopper S., Fleckenstein B., Überla K. T. vpr. J. Virol. 69:1995;4807-4813.
21. Ink B., Zornig M., Baum B., Hajibagheri N., James K., Chittenden T., Evan G. Human Bak induces cell death inSchizosaccharomyces pombe. Mol. Cell. Biol. 17:1997;2468-2474.
22. Jowett J. B., Planelles V., Poon B., Shah N. P., Chen M., Chen I. S. Y. The human immunodeficiency virus type 1vpr. J. Virol. 69:1995;6304-6313.
23. Jurgensmeier J. M., Krajewski S., Armstrong R. C., Wilson G. M., Oltersdorf T., Fritz L. C., Reed J. C., Ottilie S. Bax- and Bak-induced cell death in the fission yeastSchizosaccharomyces pombe. Mol. Biol. Cell. 8:1997;325-339.
24. Kobori H., Yamada N., Taki A., Osumi M. Actin is associated with the formation of the cell wall in reverting protoplast of the fission yeastSchizosaccharomyces pombe. J. Cell Biol. 94:1989;635-646.
25. Kretschmar M., Nichterlein T., Nebe C. T., Hof H., Burger K. J. Fungicidal effect of tyrothricin onCandida albicans. Mycoses. 39:1996;45-50.
26. Lang S., Weeger M. M., Stahl-Hennig C., Coulibaly C., Hunsmann G., Juller J., Juller- Hermelink H., Fuchs D., Wachter H., Daniel M. M., Destosiers R. C., Fleckenstein B. Importance ofvpr. J. Virol. 67:1993;902-912.
27. Levy D. N., Fernandes L. S., Williams W. V., Weiner D. B. Induction of cell differentiation by human immunodeficiency virus 1vpr. Cell. 72:1993;541-550.
28. Levy D. N., Refaeli Y., MacGregor R. R., Weiner D. B. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 91:1994;10873-10877.
29. Levy D. N., Refaeli Y., Weiner D. B. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69:1995;1243-1252.
30. Li X., James W. M., Traganos F., Darzynkiewcz Z. Application of biotin, digoxigenin or fluorescein conjugated deoxynucleotides to label DNA strand breaks for analysis of cell proliferation and apoptosis using flow cytometry. Biotechnic Histochem. 70:1995;234-242.
31. Macreadie I. G., Castelli L. A., Hewish D. R., Kirkpatrick A., Ward A. C., Azad A. A. A domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects. Proc. Natl. Acad. Sci. USA. 92:1995;2770-2774.
32. Mansky L. M. The mutation rate of human immunodeficiency virus type 1 is influenced by thevpr. Virology. 222:1996;391-400.
33. Mark J., Hyams J. S. Localization of F-actin through the cell division cycle ofSchizosaccharomyces pombe. Eur. J. Cell Biol. 39:1985;27-32.
34. +. EMBO J. 14:1995;3325-3338.
35. Maundrell K. nmt1. J. Biol. Chem. 265:1990;10857-10864.
36. Maundrell K. Thiamine-repressible expression vectors pREP and pRIP for fission yeast. Gene. 123:1993;127-130.
37. Mitchison J. M., Nurse P. Growth in cell length in the fission yeastSchizosaccharomyces pombe. J. Cell Sci. 75:1985;357-376.
38. Mulholland J., Preuss D., Moon A., Wong A., Drubin D., Botstein D. Ultrastructure of the yeast actin cytoskeleton and its association with the plasma membrance. J. Cell Biol. 125:1994;381-391.
39. Oberhammer F., Fritsch G., Schmied M., Pavelka M., Printz D., Purchio T., Lassmann H., Schulte-Hermann R. Condensation of the chromatin at the membrance of an apoptotic nucleus is not associated with activation of an endonuclease. J. Cell Sci. 104:1993;317-326.
40. O'Connor P. M., Ferris D. K., Pagano M., Draetta G., Pines J., Hunter T., Longo D. L., Kohn K. W. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complex. J. Biol. Chem. 268:1993;8298-8308.
41. Ohsaki Y., Ishida S., Fujikane T., Kikuchi K. Pentoxifylline potentiates the antitumor effect of cisplatin and etoposide on human lung cancer cell lines. Oncology. 53:1996;327-333.
42. Poon B., Jowett J. B., Stewart S. A., Armstrong R. W., Rishton G. M., Chen I. S. Human immunodeficiency virus type 1vpr. J. Virol. 71:1997;3961-3971.
43. Re F., Braaten D., Franke E. K., Luban J. Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69:1995;6859-6864.
44. Refaeli Y., Levy D. N., Weiner D. B. The glucocorticoid receptor type II complex is a target of the HIV-1vpr. Proc. Natl. Acad. Sci. USA. 92:1995;3621-3625.
45. Rogel M. E., Wu L. I., Emerman M. The human immunodeficiency virus type 1vpr. J. Virol. 69:1995;882-888.
46. Sharp P. M., Bailes E., Stevenson M., Emerman M., Hahn B. H. Gene acquisition in HIV and SIV. Nature. 383:1996;586-587.
47. Smith C. L., Matsumoto T., Niwa O., Klco S., Fan J., Yanagida M., Cantor C. R. Electrophoretic karyotype forSchizosaccharomyces pombe. Nucleic Acids Res. 15:1987;4481-4489.
48. Stewart S. A., Poon B., Jowett J. B., Chen I. S. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71:1997;5579-5592.
49. Toda T., Yamamoto M., Yanagida M. Sequential alterations in the nuclear chromatin region during mitosis of the fission yeastSchizosaccharomyces pombe:cdc. J. Cell Sci. 52:1981;271-287.
50. Traganos F., Kapuscinski J., Darzynkiewicz Z. Caffeine modulates the effects of DNA-intercalating drugsin vitro: Cancer Res. 51:1991;3682-3689.
51. Tristem M., Marshall C., Karpas A., Hill F. Evolution of the primate lentiviruses: evidence from vpx andvpr. EMBO J. 11:1992;3405-3412.
52. Turmel C., Lalande M. Resolution ofSchizosaccharomyces pombe. Nucleic Acids Res. 16:1988;4727.
53. Walker P. R., Kokileva L., LeBlanc J., Sikorska M. Detection of the initial stages of DNA fragmentation in apoptosis. BioTechniques. 15:1993;1032-1040.
54. Wang L., Mukherjee S., Jia F., Narayan O., Zhao L. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and transactivation of viral long terminal repeat. J. Biol. Chem. 270:1995;25564-25569.
55. Whitters E. A., Cleves A. E., McGee T. P., Skinner H. B., Bankaitis V. A. Sac1p is an integral membrance protein that influences the cellular requirement for phospholipid transfer protein function and inositol in yeast. J. Cell Biol. 122:1993;79-94.
56. Wyllie A. H. Cell death: A new classification separating apoptosis from necrosis. Cell Death in Biology and Pathology. 1981;Chapman & Hall, New York. p. 9-34.
57. Zhang C., Rasmussen C., Chang L.-J. Cell cycle inhibitory effects of HIV and SIV Vpr and Vpx in the yeastSchizosaccharomyces pombe. Virology. 230:1997;103-112.
58. Zhao Y., Cao J., O'Gorman M. R. G., Yu M., Yogev R. Effect of human immunodeficiency virus Type 1 protein R (vprSchizosaccharomyces pombe. J. Virol. 70:1996;5821-5826.
59. Zhao Y., Lu Y. Lithium-acetate based protocol for yeast transformation. Li Y. M., Zhao Y. Practical Protocols in Molecular Biology. 1996;63-64 Science Press, New York.